356 related articles for article (PubMed ID: 26122937)
21. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognostic impact of osteopontin and Dickkopf-related protein 1 in patients with hepatocellular carcinoma after hepatectomy.
Byeon H; Lee SD; Hong EK; Lee DE; Kim BH; Seo Y; Joo J; Han SS; Kim SH; Park SJ
Pathol Res Pract; 2018 Jun; 214(6):814-820. PubMed ID: 29753515
[TBL] [Abstract][Full Text] [Related]
23. Comparison osteopontin vs AFP for the diagnosis of HCC: a meta-analysis.
Wan HG; Xu H; Gu YM; Wang H; Xu W; Zu MH
Clin Res Hepatol Gastroenterol; 2014 Dec; 38(6):706-14. PubMed ID: 25034355
[TBL] [Abstract][Full Text] [Related]
24. Meta-analysis of the prognostic and diagnostic significance of serum/plasma osteopontin in hepatocellular carcinoma.
Cheng J; Wang W; Sun C; Li M; Wang B; Lv Y
J Clin Gastroenterol; 2014 Oct; 48(9):806-14. PubMed ID: 24247813
[TBL] [Abstract][Full Text] [Related]
25. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
[TBL] [Abstract][Full Text] [Related]
26. Risk of hepatocellular carcinoma in HBV cirrhotic patients assessed by the combination of miR-122, AFP and PIVKA-II.
Caviglia GP; Abate ML; Gaia S; Petrini E; Bosco C; Olivero A; Rosso C; Ciancio A; Pellicano R; Saracco GM; Rizzetto M; Smedile A
Panminerva Med; 2017 Dec; 59(4):283-289. PubMed ID: 28650134
[TBL] [Abstract][Full Text] [Related]
27. Feasibility of α-fetoprotein as a diagnostic tool for hepatocellular carcinoma in Korea.
Ahn DG; Kim HJ; Kang H; Lee HW; Bae SH; Lee JH; Paik YH; Lee JS
Korean J Intern Med; 2016 Jan; 31(1):46-53. PubMed ID: 26767857
[TBL] [Abstract][Full Text] [Related]
28. Human liver carboxylesterase 1 outperforms alpha-fetoprotein as biomarker to discriminate hepatocellular carcinoma from other liver diseases in Korean patients.
Na K; Jeong SK; Lee MJ; Cho SY; Kim SA; Lee MJ; Song SY; Kim H; Kim KS; Lee HW; Paik YK
Int J Cancer; 2013 Jul; 133(2):408-15. PubMed ID: 23319432
[TBL] [Abstract][Full Text] [Related]
29. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
[TBL] [Abstract][Full Text] [Related]
30. Impact of etiology of chronic liver disease on hepatocellular carcinoma biomarkers.
Ricco G; Cavallone D; Cosma C; Caviglia GP; Oliveri F; Biasiolo A; Abate ML; Plebani M; Smedile A; Bonino F; Pontisso P; Brunetto MR
Cancer Biomark; 2018 Feb; 21(3):603-612. PubMed ID: 29278878
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
[TBL] [Abstract][Full Text] [Related]
32. Serum biomarkers for early detection of hepatocellular carcinoma associated with HCV infection in egyptian patients.
Zekri AR; Youssef AS; Bakr YM; Gabr RM; El-Rouby MN; Hammad I; Ahmed EA; Marzouk HA; Nabil MM; Hamed HA; Aly YH; Zachariah KS; Esmat G
Asian Pac J Cancer Prev; 2015; 16(3):1281-7. PubMed ID: 25735368
[TBL] [Abstract][Full Text] [Related]
33. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
34. Elevated plasma osteopontin level is predictive of cirrhosis in patients with hepatitis B infection.
Zhao L; Li T; Wang Y; Pan Y; Ning H; Hui X; Xie H; Wang J; Han Y; Liu Z; Fan D
Int J Clin Pract; 2008 Jul; 62(7):1056-62. PubMed ID: 17537188
[TBL] [Abstract][Full Text] [Related]
35. The utility of Lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a United States referral population.
Leerapun A; Suravarapu SV; Bida JP; Clark RJ; Sanders EL; Mettler TA; Stadheim LM; Aderca I; Moser CD; Nagorney DM; LaRusso NF; de Groen PC; Menon KV; Lazaridis KN; Gores GJ; Charlton MR; Roberts RO; Therneau TM; Katzmann JA; Roberts LR
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):394-402; quiz 267. PubMed ID: 17368240
[TBL] [Abstract][Full Text] [Related]
36. Development and Internal Validation of a Model for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis.
Patel J; Yopp A; Waljee AK; Singal AG
J Clin Gastroenterol; 2016 Feb; 50(2):175-9. PubMed ID: 26125462
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of annexin A2 and as potential biomarkers for hepatocellular carcinoma.
El-Abd N; Fawzy A; Elbaz T; Hamdy S
Tumour Biol; 2016 Jan; 37(1):211-6. PubMed ID: 26189841
[TBL] [Abstract][Full Text] [Related]
38. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
[TBL] [Abstract][Full Text] [Related]
39. Alpha-Fetoprotein Measurement Benefits Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis.
Chang TS; Wu YC; Tung SY; Wei KL; Hsieh YY; Huang HC; Chen WM; Shen CH; Lu CH; Wu CS; Tsai YH; Huang YH
Am J Gastroenterol; 2015 Jun; 110(6):836-44; quiz 845. PubMed ID: 25869392
[TBL] [Abstract][Full Text] [Related]
40. The prognostic significance of preoperative plasma levels of osteopontin in patients with TNM stage-I of hepatocellular carcinoma.
Sun J; Xu HM; Zhou HJ; Dong QZ; Zhao Y; Fu LY; Hei ZY; Ye QH; Ren N; Jia HL; Qin LX
J Cancer Res Clin Oncol; 2010 Jan; 136(1):1-7. PubMed ID: 19593583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]